Publications by authors named "O Dewit"

Claim this Profile
E
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease.
Marla C Dubinsky, Geert D'Haens, Olivier Dewit, Pascal Juillerat, Remo Panaccione

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.
A Cremer, A Mansour, T Lobaton, P Bossuyt, J Rahier, O Dewit, S Dewit

Acta Gastroenterol Belg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Pauline Wils, Romain Altwegg, Anthony Buisson, Lucine Vuitton, Stephane Nancey, Olivier Dewit

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study.
An Outtier, Edouard Louis, Olivier Dewit, Catherine Reenaers, Ganel Schops

Clin Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib for Treatment of Granulomatous Cheilitis.
Axel De Greef, Caroline Peeters, Olivier Dewit, Laurence de Montjoye, Marie Baeck

JAMA Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis